...
首页> 外文期刊>Breathe >GPs Meet Rare Lung Disorders Task Force factsheet: α-1 antitrypsin deficiency
【24h】

GPs Meet Rare Lung Disorders Task Force factsheet: α-1 antitrypsin deficiency

机译:全科医生遇到罕见的肺部疾病工作队简介:α-1抗胰蛋白酶缺乏症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

h3Definition/h3pα-1 antitrypsin deficiency (AATD) is a genetic disorder that manifests as pulmonary emphysema, liver cirrhosis and, rarely, as the skin disease panniculitis, or as vasculitis and is characterised by low serum levels of AAT, the main protease inhibitor in human serum./ph3Key messages/h3pThink about AATD if your patient had emphysema at younger age./ppAssess the levels of blood AAT to ascertain the diagnosis by the finding of reduced levels./ppRefer the patient to a Department with experience in lung/liver manifestations of AATD./ppFollow the patient longitudinally in collaboration with the reference center. Issues to consider are replacement therapy (if needed or available) and clinical evolution toward respiratory or liver failure./p
机译:>定义 >α-1抗胰蛋白酶缺乏症(AATD)是一种遗传性疾病,表现为肺气肿,肝硬化,很少表现为皮肤病,脂膜炎或血管炎,其特征是血清低人血清中主要蛋白酶抑制剂AAT的水平。 >要点 >如果您的患者在年轻时患有肺气肿,请考虑AATD。 >评估水平血液中AAT的水平降低,从而确定诊断。 >将患者转诊至具有AATD肺/肝表现经验的部门。 >纵向跟踪患者与参考中心。需要考虑的问题是替代疗法(如果需要或可用)以及对呼吸衰竭或肝衰竭的临床进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号